MG-262 Catalog No.:M22681-C Kanamycin A was first isolated

Kanamycin A was first isolated in 1957 by Hamao Umezawa from the bacterium Streptomyces kanamyceticus

selective and orally active 5-HT1A/1B/1D receptor antagonist with pKi values of 9

There is an 87

Pomalidomide 4-alkylC7-acid

IDO-IN-5 (Compound 1487) is an indoleamine 2

MG-262 Catalog No.:M22681-C Kanamycin A was first isolatedMG 262 (also known as Z Leu Leu Leu B(OH)2), a boronic peptide acid, is a potent proteasome inhibitor that selectively and reversibly inhibits the chymotryptic activity of the proteasome. It consists of a peptide and boronic acid moiety which are functional to proteasome inhibition. According to previous studies, MG 262 is capable of reducing the viability of nasal mucosa and polyp fibroblasts, provoking cell growth arrest, inhibiting DNA replication